{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:07:17Z","timestamp":1791389237298,"version":"4.3.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Horizon Therapeutics plc"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40123-020-00318-x","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T14:09:50Z","timestamp":1605535790000},"page":"75-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States"],"prefix":"10.1007","volume":"10","author":[{"given":"Yao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lissa","family":"Padnick-Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Francis-Sedlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Massry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond S.","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"318_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","volume":"121","author":"GB Bartley","year":"1996","unstructured":"Bartley GB, Fatourechi V, Kadrmas EF, et al. Clinical features of Graves\u2019 ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996;121:284\u201390.","journal-title":"Am J Ophthalmol"},{"key":"318_CR2","first-page":"1","volume-title":"Graves' orbitopathy: a multidisciplinary approach\u2014questions and answers","author":"AJ Dickinson","year":"2017","unstructured":"Dickinson AJ, Hintschich C. Clinical manifestations. In: Wiersinga WM, Kahaly GJ, editors. Graves\u2019 orbitopathy: a multidisciplinary approach\u2014questions and answers. 3rd ed. Basel: Karger; 2017. p. 1\u201325.","edition":"3"},{"key":"318_CR3","first-page":"113","volume":"29","author":"IB Hales","year":"1960","unstructured":"Hales IB, Rundle FF. Ocular changes in Graves\u2019 disease. A long-term follow-up study. Q J Med. 1960;29:113\u201326.","journal-title":"Q J Med."},{"key":"318_CR4","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1056\/NEJMcp0806317","volume":"360","author":"L Bartalena","year":"2009","unstructured":"Bartalena L, Tanda ML. Clinical practice. Graves\u2019 ophthalmopathy. N Engl J Med. 2009;360:994\u20131001.","journal-title":"N Engl J Med"},{"key":"318_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000477803","volume":"6","author":"E Sabini","year":"2017","unstructured":"Sabini E, Leo M, Mazzi B, et al. Does Graves\u2019 orbitopathy ever disappear? Answers to an old question. Eur Thyroid J. 2017;6:263\u201370.","journal-title":"Eur Thyroid J"},{"key":"318_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1365-2265.2007.03087.x","volume":"68","author":"S Estcourt","year":"2008","unstructured":"Estcourt S, Vaidya B, Quinn A, Shepherd M. The impact of thyroid eye disease upon patients\u2019 wellbeing: a qualitative analysis. Clin Endocrinol (Oxf). 2008;68:635\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"318_CR7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/EJE-07-0205","volume":"157","author":"I Coulter","year":"2007","unstructured":"Coulter I, Frewin S, Krassas GE, Perros P. Psychological implications of Graves\u2019 orbitopathy. Eur J Endocrinol. 2007;157:127\u201331.","journal-title":"Eur J Endocrinol"},{"key":"318_CR8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1530\/EJE-11-0055","volume":"164","author":"S Estcourt","year":"2011","unstructured":"Estcourt S, Quinn AG, Vaidya B. Quality of life in thyroid eye disease: impact of quality of care. Eur J Endocrinol. 2011;164:649\u201355.","journal-title":"Eur J Endocrinol"},{"key":"318_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1089\/thy.1997.7.885","volume":"7","author":"MN Gerding","year":"1997","unstructured":"Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF, Wiersinga WM. Quality of life in patients with Graves\u2019 ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid. 1997;7:885\u20139.","journal-title":"Thyroid"},{"key":"318_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1089\/105072502753600205","volume":"12","author":"GJ Kahaly","year":"2002","unstructured":"Kahaly GJ, Hardt J, Petrak F, Egle UT. Psychosocial factors in subjects with thyroid-associated ophthalmopathy. Thyroid. 2002;12:237\u20139.","journal-title":"Thyroid"},{"key":"318_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2265.2005.02352.x","volume":"63","author":"GJ Kahaly","year":"2005","unstructured":"Kahaly GJ, Petrak F, Hardt J, Pitz S, Egle UT. Psychosocial morbidity of Graves\u2019 orbitopathy. Clin Endocrinol (Oxf). 2005;63:395\u2013402.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"318_CR12","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.ophtha.2006.02.060","volume":"113","author":"EA Bradley","year":"2006","unstructured":"Bradley EA, Sloan JA, Novotny PJ, Garrity JA, Woog JJ, West SK. Evaluation of the National Eye Institute visual function questionnaire in Graves\u2019 ophthalmopathy. Ophthalmology. 2006;113:1450\u20134.","journal-title":"Ophthalmology"},{"key":"318_CR13","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/ICU.0b013e32827038f2","volume":"18","author":"EO Schotthoefer","year":"2007","unstructured":"Schotthoefer EO, Wallace DK. Strabismus associated with thyroid eye disease. Curr Opin Ophthalmol. 2007;18:361\u20135.","journal-title":"Curr Opin Ophthalmol"},{"key":"318_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.ajo.2013.12.023","volume":"157","author":"AJ Paulsen","year":"2014","unstructured":"Paulsen AJ, Cruickshanks KJ, Fischer ME, et al. Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol. 2014;157:799\u2013806.","journal-title":"Am J Ophthalmol"},{"key":"318_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","volume":"5","author":"L Bartalena","year":"2016","unstructured":"Bartalena L, Baldeschi L, Boboridis K, et al. The 2016 European Thyroid Association\/European Group on Graves\u2019 Orbitopathy Guidelines for the management of Graves\u2019 orbitopathy. Eur Thyroid J. 2016;5:9\u201326.","journal-title":"Eur Thyroid J"},{"key":"318_CR16","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1089\/thy.2016.0229","volume":"26","author":"DS Ross","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26:1343\u2013421.","journal-title":"Thyroid"},{"key":"318_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1530\/eje.0.1510549","volume":"151","author":"TV Elberling","year":"2004","unstructured":"Elberling TV, Rasmussen AK, Feldt-Rasmussen U, Hording M, Perrild H, Waldemar G. Impaired health-related quality of life in Graves\u2019 disease. A prospective study. Eur J Endocrinol. 2004;151:549\u201355.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"318_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1530\/eje.0.1460751","volume":"146","author":"C Terwee","year":"2002","unstructured":"Terwee C, Wakelkamp I, Tan S, Dekker F, Prummel MF, Wiersinga W. Long-term effects of Graves\u2019 ophthalmopathy on health-related quality of life. Eur J Endocrinol. 2002;146(6):751\u20137.","journal-title":"Eur J Endocrinol"},{"key":"318_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.beem.2011.11.001","volume":"26","author":"WM Wiersinga","year":"2012","unstructured":"Wiersinga WM. Quality of life in Graves\u2019 ophthalmopathy. Best Pract Res Clin Endocrinol Metab. 2012;26:359\u201370.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"318_CR20","first-page":"164","volume":"4","author":"M Bahmani-Kashkouli","year":"2009","unstructured":"Bahmani-Kashkouli M, Pakdel F, Astaraki A, et al. Quality of life in patients with thyroid eye disease. J Ophthalmic Vis Res. 2009;4:164\u20138.","journal-title":"J Ophthalmic Vis Res"},{"key":"318_CR21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/eye.2011.359","volume":"26","author":"YJ Choi","year":"2012","unstructured":"Choi YJ, Lim HT, Lee SJ, Lee SY, Yoon JS. Assessing Graves\u2019 ophthalmopathy-specific quality of life in Korean patients. Eye (London). 2012;26:544\u201351.","journal-title":"Eye (London)"},{"key":"318_CR22","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jfma.2013.12.002","volume":"114","author":"IC Lin","year":"2015","unstructured":"Lin IC, Lee CC, Liao SL. Assessing quality of life in Taiwanese patients with Graves\u2019 ophthalmopathy. J Formos Med Assoc. 2015;114:1047\u201354.","journal-title":"J Formos Med Assoc"},{"key":"318_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/bjo.88.1.75","volume":"88","author":"JJ Park","year":"2004","unstructured":"Park JJ, Sullivan TJ, Mortimer RH, Wagenaar M, Perry-Keene DA. Assessing quality of life in Australian patients with Graves\u2019 ophthalmopathy. Br J Ophthalmol. 2004;88:75\u20138.","journal-title":"Br J Ophthalmol"},{"key":"318_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fendo.2019.00192","volume":"10","author":"D Villagelin","year":"2019","unstructured":"Villagelin D, Romaldini J, Andrade J, et al. Evaluation of quality of life in the Brazilian Graves\u2019 disease population: focus on mild and moderate Graves\u2019 orbitopathy patients. Front Endocrinol (Lausanne). 2019;10:192.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"318_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1590\/2359-3997000000252","volume":"61","author":"LC Delfino","year":"2017","unstructured":"Delfino LC, Zunino A, Sapia V, Croome M, Ilera V, Gauna AT. Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in a population of patients with Graves\u2019 disease. Arch Endocrinol Metab. 2017;61:374\u201381.","journal-title":"Arch Endocrinol Metab"},{"key":"318_CR26","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1089\/thy.2013.0240","volume":"24","author":"F Menconi","year":"2014","unstructured":"Menconi F, Profilo MA, Leo M, et al. Spontaneous improvement of untreated mild Graves\u2019 ophthalmopathy: Rundle\u2019s curve revisited. Thyroid. 2014;24:60\u20136.","journal-title":"Thyroid"},{"key":"318_CR27","first-page":"36","volume":"6","author":"FF Rundle","year":"1957","unstructured":"Rundle FF. Management of exophthalmos and related ocular changes in Graves\u2019 disease. Metabolism. 1957;6:36\u201348.","journal-title":"Metabolism"},{"key":"318_CR28","first-page":"369","volume":"136","author":"PJ Agapitos","year":"1987","unstructured":"Agapitos PJ, Hart IR. Long-term follow-up of ophthalmic Graves\u2019 disease. CMAJ. 1987;136:369\u201372.","journal-title":"CMAJ"},{"key":"318_CR29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1136\/bjo.82.7.773","volume":"82","author":"CB Terwee","year":"1998","unstructured":"Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM. Development of a disease specific quality of life questionnaire for patients with Graves\u2019 ophthalmopathy: the GO-QOL. Br J Ophthalmol. 1998;82:773\u20139.","journal-title":"Br J Ophthalmol"},{"key":"318_CR30","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1023\/A:1016647407161","volume":"9","author":"KA Wilson","year":"2000","unstructured":"Wilson KA, Dowling AJ, Abdolell M, Tannock IF. Perception of quality of life by patients, partners and treating physicians. Qual Life Res. 2000;9:1041\u201352.","journal-title":"Qual Life Res"},{"key":"318_CR31","first-page":"164","volume":"103","author":"GR Beauchamp","year":"2005","unstructured":"Beauchamp GR, Felius J, Stager DR, Beauchamp CL. The utility of strabismus in adults. Trans Am Ophthalmol Soc. 2005;103:164\u201371.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"318_CR32","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3389\/fneur.2017.00729","volume":"8","author":"MC Ysrraelit","year":"2017","unstructured":"Ysrraelit MC, Fiol MP, Gaitan MI, Correale J. Quality of life assessment in multiple sclerosis: different perception between patients and neurologists. Front Neurol. 2017;8:729.","journal-title":"Front Neurol"},{"key":"318_CR33","first-page":"5","volume":"22","author":"R Likert","year":"1932","unstructured":"Likert R. A technique for the measurement of attitudes. Arch Psychol. 1932;22:5\u201355.","journal-title":"Arch Psychol"},{"key":"318_CR34","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0022-3999(99)00051-3","volume":"47","author":"SM Skevington","year":"1999","unstructured":"Skevington SM. Measuring quality of life in Britain: introducing the WHOQOL-100. J Psychosom Res. 1999;47:449\u201359.","journal-title":"J Psychosom Res"},{"key":"318_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0001-6918(99)00050-5","volume":"104","author":"CC Preston","year":"2000","unstructured":"Preston CC, Colman AM. Optimal number of response categories in rating scales: reliability, validity, discriminating power, and respondent preferences. Acta Psychol (Amst). 2000;104:1\u201315.","journal-title":"Acta Psychol (Amst)"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-020-00318-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40123-020-00318-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-020-00318-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T02:45:56Z","timestamp":1613702756000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40123-020-00318-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["318"],"URL":"https:\/\/doi.org\/10.1007\/s40123-020-00318-x","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]},"assertion":[{"value":"18 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}